CONTACT US
current location:
In the pharmaceutical sector, the trend of share reduction continues, with several pharmaceutical companies experiencing multiple rounds of share reduction
Source:JINDUN MEDICAL | Author:JINDUN MEDICAL | Published time: 2023-05-17 | 325 Views | Share:

On May 15th, according to the information from the Hong Kong Stock Exchange, The Capital Group Companies, Inc. recently increased its holdings of WuXi AppTec by 1.05 million shares at a price of HKD 69.0340 per share, with a total amount of HKD 724.857 million. The latest holding after the increase is approximately 24.1851 million shares, accounting for a stake of 6.01%.


Although The Capital Group Companies has increased its holdings, WuXi AppTec recently experienced a reduction in holdings. On the evening of April 17th, WuXi AppTec issued a reduction in holdings announcement. According to the announcement, the controlling shareholder and concerted action parties of WuXi AppTec (the reducing entities) planned to reduce their A-share holdings through block trading and/or bulk transactions, with a total reduction of up to 89.0227 million shares, not exceeding 3% of the total share capital, due to their own capital requirements.


It is understood that since 2021, WuXi AppTec has issued multiple reduction in holdings plans. According to statistics, from July 2nd, 2019, to September 30th, 2021, WuXi AppTec shareholders have accumulated 106 instances of buying and selling behavior, with a total reduction amount of CNY 32.61 billion.


Subsequently, in June 2022, WuXi AppTec issued an announcement on the "Shareholders' Reduction in Shareholding Plan", stating that the relevant parties of the controlling shareholder intended to reduce their shareholding by no more than 3% due to their own capital requirements, with a cash-out amount of nearly CNY 9 billion calculated based on the closing price of that day. The previous reduction plan was announced on the evening of November 25th last year when WuXi AppTec stated that, due to its own capital requirements, the controlling shareholder and shareholders who had signed a concerted action agreement planned to reduce their holdings by no more than 65 million shares, not exceeding 2.2% of the total share capital.


In addition to WuXi AppTec, numerous reductions have taken place in the pharmaceutical sector since the 2023 financial reporting season.


On the same day, The Capital Group Companies, Inc. reduced its holdings of CanSino Biologics by 594,800 shares at a price of HKD 33.822 per share, with a total amount of approximately HKD 201.173 million. The latest holding after the reduction is approximately 23.6902 million shares, accounting for a stake of 17.86%.


On May 14th, RuiKang Pharmaceutical announced that its controlling shareholder and actual controller, Han Xu and Zhang Renhua, had cumulatively reduced their holdings of the company's shares by 30.04 million shares through bulk transactions between March 29th and May 11th, 2023, accounting for 1.9964% of the total share capital.


On the evening of May 12th, ZhaoYan New Drug announced that shareholder Gu Meifang planned to reduce her holdings of the company's shares by no more than 3.22 million shares through block trading on the Shanghai Stock Exchange, not exceeding 0.6011% of the current total share capital. As of now, Gu Meifang holds 10.592882 million shares of the company, accounting for a stake of 1.9775%. It is worth mentioning that on April 20th, ZhaoYan New Drug announced that it had experienced substantial reductions in holdings by a large number of directors and senior management personnel, with a total reduction not exceeding 4.268293 million shares


On May 12th, Kanghui Pharmaceutical released an announcement stating that its major shareholder, TBP Company, planned to reduce its total shareholding by no more than 5.99 million shares (i.e., not exceeding 6% of the total share capital) through block trading and bulk transactions.


On May 9th, Kunyao Group issued an announcement stating that its shareholder, Huali Pharmaceutical Group Co., Ltd., had cumulatively reduced its holdings by 400,000 shares from February 21st to May 9th, 2023, accounting for 0.0528% of the company's current total share capital...